Women and men have the same risk factors for CVD, right? WRONG!

🚫🚫🚫

Keep reading for a tweetorial on CVD in women!

@erinmichos @drmarthagulati @cardiopcimom @gina_lundberg @KBerlacher @shreyarao87 @DrLaxmiMehta @MinnowWalsh @MedTweetorials
What have we learned about women's CVD disease since 1966?

In light of #wearredday celebrating #WIC, we will explore:

(1) the traditional ASCVD risk score

(2) female-specific ASCVD risk-enhancers

(3) female-predominant ASCVD risk-enhancers
Poll -

I feel comfortable identifying female-specific and –predominant factors that may modify our assessment of an individual's lifetime ASCVD risk.
To guide individual prevention recs, we use the Pooled Cohort Equations that ➡️ Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score.

Using the exact same PMHx, SBP, cholesterol, and smoking history, you get a different risk assessment for men and women.
But do these factors fully capture our patient's risk? What else should we consider? Let's review the guidelines! 🧐
New in 2019, the ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease called for physicians to consider RISK-ENHANCING FACTORS specific to women.

So what are some of these risk-enhancers? https://www.sciencedirect.com/science/article/pii/S073510971933877X?via%3Dihub
Let's start with gestational hypertension and preeclampsia. In this study, preeclampsia was assc with a HR of 1.8 for incidence of CAD vs those w/o preeclampsia.

Thought due to accelerated cardiovascular aging and persistent arterial stiffness

https://www.jacc.org/cms/asset/1d0d8a4c-99a6-4f48-a55f-c6ec219999ec/gr3.jpg
Keep in mind, hypertensive disorders in pregnancy are not only associated with increased incidence of CAD but also other cardiovascular conditions including valvular disease and heart failure -- NOT entirely mediated by ongoing chronic hypertension

https://www.cardionerds.com/66-case-report-severe-pre-eclampsia-cardio-obstetrics-upmc/
Other pregnancy related risk-enhancers = preterm delivery (⬆️ <37 weeks + ⬆️⬆️ <32 weeks) and small for gestational size infants.
Inflammatory + autoimmune conditions that largely affect women AND confer ⬆️ CVD risk include:
-rheumatoid arthritis
-scleroderma
-SLE

Related to underlying inflammation + oxidative stress, as well as treatments (I.e. steroids)

…https://pubmed-ncbi-nlm-nih-gov.ucsf.idm.oclc.org/29685876/#&gid=article-figures&pid=fig-3-uid-2
Early menopause also confers an increased risk of coronary artery disease.

Despite the ⬆️ risk, remember that the Women's Health Initiative did NOT show that HRT is cardioprotective
A good obstetrics history is critical to accurately assessing CV risk! Make sure to ask about PCOS, OCP use, hormone replacement therapy, and oncologic history including history of breast cancer +/- treatment

https://www.ahajournals.org/cms/asset/7d5fc228-477a-4196-91c8-d3e00c0a893e/1273fig01.jpeg
In summary, in light of #wearredday , let's remember to screen women for female-specific and female-predominant conditions that may modify CVD risk and are not included in the PCE!

For applied cases, see expert discussion by @DrMarthaGulati here -

https://www.cardionerds.com/18-womens-cardiovascular-health-with-dr-martha-gulati/
Poll:

I feel comfortable identifying female-specific and –predominant factors that may modify our assessment of an individual's lifetime ASCVD risk.
I learned something in this Tweetorial that may change my clinical practice.
Thanks for reading! Would love to hear any thoughts and feedback.

As always, thank you to the @cardionerds family for support and feedback – particularly @ThomasMDas!
You can follow @jholtzman3.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.